Sign In
Buy BDX
$170.12
-0.0900 (-0.0529%)
At Close: Aug 04, 2026
BD Names Michael Feld as President of Life Sciences Segment
06:50am, Monday, 12'th Aug 2024
FRANKLIN LAKES, N.J. , Aug. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named execu
10 High-Yield Dividend Aristocrats That Could Be Perfect For What's Coming Next
07:00am, Saturday, 10'th Aug 2024
Market volatility recently hit the 3rd highest levels ever recorded, and extreme fear grips Wall Street. The yen carry trade unwind is likely not over yet; US recession risks remain elevated, and the
BD to Present at Wells Fargo 2024 Healthcare Conference
04:15pm, Thursday, 08'th Aug 2024
FRANKLIN LAKES, N.J. , Aug. 8, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo
The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024
07:00am, Thursday, 08'th Aug 2024
Dividends have played a significant role in the total returns of equity investments. The practice of consistently increasing dividends can be seen in the S&P 500 Dividend Aristocrats.
Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy
04:24am, Tuesday, 06'th Aug 2024
Becton, Dickinson is overwhelmingly considered undervalued by Wall Street analysts, with an average price target of ~$280 and highs of $312-$330. This is supported by my extensive DCF and comps models
BD (BDX) Q3 Earnings Surpass Estimates, Margins Expand
02:00pm, Thursday, 01'st Aug 2024
BD's (BDX) overall topline benefits from revenue growth in all segments in the fiscal third quarter.
Becton, Dickinson and Company (BDX) Q3 2024 Earnings Call Transcript
12:55pm, Thursday, 01'st Aug 2024
Becton, Dickinson and Company (NYSE:BDX ) Q3 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer & Head of Investor Relations T
Compared to Estimates, Becton Dickinson (BDX) Q3 Earnings: A Look at Key Metrics
10:36am, Thursday, 01'st Aug 2024
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall
Becton Dickinson (BDX) Q3 Earnings Beat Estimates
08:45am, Thursday, 01'st Aug 2024
Becton Dickinson (BDX) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.31 per share. This compares to earnings of $2.96 per share a year ago.
Becton Dickinson tops profit estimates on demand for drug-delivery devices
08:27am, Thursday, 01'st Aug 2024
Becton Dickinson reported a better-than-expected third-quarter profit on Thursday, helped by strong demand for its drug-delivery devices.
BD Reports Third Quarter Fiscal 2024 Financial Results
06:30am, Thursday, 01'st Aug 2024
Strong Margin Execution Drives Performance in Quarter Revenue of $5.0 billion as reported, adjusted revenue of $5.1 billion, driven by strong organic revenue growth GAAP and adjusted diluted EPS of $1
Sustained Product Demand Likely to Aid BD's (BDX) Q3 Earnings
01:21pm, Monday, 29'th Jul 2024
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal third-quarter revenues.
Countdown to Becton Dickinson (BDX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 29'th Jul 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Becton Dickinson (BDX), delve into some of its key metrics to gain a deeper insight into the company's potential performance fo
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
06:45am, Thursday, 25'th Jul 2024
Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J.
BD Board Declares Dividend
04:15pm, Tuesday, 23'rd Jul 2024
FRANKLIN LAKES, N.J. , July 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decl
